178 related articles for article (PubMed ID: 9160379)
1. Insulin formulation and delivery.
Brange J; Langkjaer L
Pharm Biotechnol; 1997; 10():343-409. PubMed ID: 9160379
[No Abstract] [Full Text] [Related]
2. The promising future of insulin therapy in diabetes mellitus.
Cheng R; Taleb N; Stainforth-Dubois M; Rabasa-Lhoret R
Am J Physiol Endocrinol Metab; 2021 May; 320(5):E886-E890. PubMed ID: 33719586
[TBL] [Abstract][Full Text] [Related]
3. [Advances in method of insulin delivery].
Anazawa S; Matsuoka K
Nihon Rinsho; 1990 Dec; 48 Suppl():1022-30. PubMed ID: 2086863
[No Abstract] [Full Text] [Related]
4. A crystal clear solution for insulin delivery.
Merkle HP; Jen A
Nat Biotechnol; 2002 Aug; 20(8):789-90. PubMed ID: 12148005
[No Abstract] [Full Text] [Related]
5. Use of insulin in diabetes: a century of treatment.
Shahani S; Shahani L
Hong Kong Med J; 2015 Dec; 21(6):553-9. PubMed ID: 26554270
[TBL] [Abstract][Full Text] [Related]
6. Future therapeutic directions; new medications and insulin delivery in a changing world for effective diabetes management.
Modi P
Curr Drug Discov Technol; 2009 Sep; 6(3):200-13. PubMed ID: 19496750
[TBL] [Abstract][Full Text] [Related]
7. Modulated release from drug delivery devices.
Heller J
Crit Rev Ther Drug Carrier Syst; 1993; 10(3):253-305. PubMed ID: 8258159
[TBL] [Abstract][Full Text] [Related]
8. Bioavailability of highly purified bovine ultralente insulin.
Home PD; Hanning I; Capaldo B; Alberti KG
Diabetes Care; 1983; 6(2):210. PubMed ID: 6343027
[No Abstract] [Full Text] [Related]
9. [Insulin detemir (NN304)].
Kaku K
Nihon Rinsho; 2002 Sep; 60 Suppl 9():511-5. PubMed ID: 12387043
[No Abstract] [Full Text] [Related]
10. [Recent trends of development of rapid-acting and long-acting human insulin analogues--its biological characteristics and clinical availability].
Yokono K
Nihon Rinsho; 2001 Nov; 59(11):2127-33. PubMed ID: 11712396
[TBL] [Abstract][Full Text] [Related]
11. Insulin's 85th anniversary--An enduring medical miracle.
Heller S; Kozlovski P; Kurtzhals P
Diabetes Res Clin Pract; 2007 Nov; 78(2):149-58. PubMed ID: 17482306
[TBL] [Abstract][Full Text] [Related]
12. [Insulin glargine (HOE901)].
Iwamoto Y
Nihon Rinsho; 2002 Sep; 60 Suppl 9():503-10. PubMed ID: 12387042
[No Abstract] [Full Text] [Related]
13. Recent approaches in insulin delivery.
Trehan A; Ali A
Drug Dev Ind Pharm; 1998 Jul; 24(7):589-97. PubMed ID: 9876502
[TBL] [Abstract][Full Text] [Related]
14. Peptide drug delivery strategies for the treatment of diabetes.
Sadrzadeh N; Glembourtt MJ; Stevenson CL
J Pharm Sci; 2007 Aug; 96(8):1925-54. PubMed ID: 17286287
[TBL] [Abstract][Full Text] [Related]
15. Oral insulin delivery: existing barriers and current counter-strategies.
Gedawy A; Martinez J; Al-Salami H; Dass CR
J Pharm Pharmacol; 2018 Feb; 70(2):197-213. PubMed ID: 29193053
[TBL] [Abstract][Full Text] [Related]
16. Alternative routes of insulin delivery.
Krishnankutty RK; Mathew A; Sedimbi SK; Suryanarayan S; Sanjeevi CB
Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2009 Oct; 34(10):933-48. PubMed ID: 19893243
[TBL] [Abstract][Full Text] [Related]
17. [Insulin analogs].
Pfützner A
Med Klin (Munich); 1996 Feb; 91 Suppl 1():17-8. PubMed ID: 8839107
[No Abstract] [Full Text] [Related]
18. Advances in phenylboronic acid-based closed-loop smart drug delivery system for diabetic therapy.
Huang Q; Wang L; Yu H; Ur-Rahman K
J Control Release; 2019 Jul; 305():50-64. PubMed ID: 31112719
[TBL] [Abstract][Full Text] [Related]
19. Drug delivery systems for the treatment of diabetes mellitus: state of the art.
Adams GG; Harding SE
Curr Pharm Des; 2013; 19(41):7244-63. PubMed ID: 23489203
[TBL] [Abstract][Full Text] [Related]
20. Premixed insulins. How do they compare with other insulin preparations?
Hollander P
Postgrad Med; 1991 Mar; 89(4):52-4, 57-8, 61. PubMed ID: 2000363
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
